Difference between revisions of "Adachi S, et al. Cancer Res. (2004) cited as Ref 132 in DOI: 10.1038/s41392-020-0110-5 (Q9395)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 64, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Role of a BCL9-related beta-catenin-binding protein B9L in tumorigenesis induced by aberrant activation of Wnt signaling, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Role of a BCL9-related beta-catenin-binding protein B9L in tumorigenesis induced by aberrant activation of Wnt signaling (English) | ||
| Property / title: Role of a BCL9-related beta-catenin-binding protein B9L in tumorigenesis induced by aberrant activation of Wnt signaling (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:52, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Adachi S, et al. Cancer Res. (2004) cited as Ref 132 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Adachi S
0 references
2004
0 references
Cancer Res.
0 references
64
0 references
Role of a BCL9-related beta-catenin-binding protein B9L in tumorigenesis induced by aberrant activation of Wnt signaling (English)
0 references
